PETS PetMed Express Inc.

PetMed Express, Inc. Sets Second Quarter 2022 Earnings Call

PetMed Express, Inc. Sets Second Quarter 2022 Earnings Call

DELRAY BEACH, Fla., Oct. 20, 2022 (GLOBE NEWSWIRE) -- (PETS) (the “Company”), Your Trusted Pet Health ExpertTM, will hold a conference call on Monday, November 7, 2022 at 4:30pm Eastern Time to discuss its financial results for the second quarter ended September 30, 2022. Financial results will be issued in a press release prior to the call.

PetMed Express management will host the conference call, followed by a question and answer session.

Date: Monday, November 7, 2022

Time: 4:30 Eastern Time (1:30 Pacific Time)

U.S. dial-in number: 877-407-0789

International number: 201-689-8562

The Company will also provide a link at for those who wish to stream the call via webcast. Please call the conference telephone number 5-10 minutes prior to the start time.

A telephonic replay of the conference call will also be available through November 21, 2022.

Toll-free replay number: 844-512-2921

International replay number: 412-317-6671

Replay passcode: 13733883

About PetMed Express

Founded in 1996, PetMeds is Your Trusted Pet Health ExpertTM, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and through its website at .

Investor Contact:

MZ North America

Brian M. Prenoveau, CFA



(561) 374-0177

Media Relations:

Mary Eva Tredway



EN
20/10/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PetMed Express Inc.

 PRESS RELEASE

PetMed Express Comments on Unsolicited and Non-Binding Acquisition Pro...

PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited No Stockholder Action Required at this Time DELRAY BEACH, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company” or “PetMeds”), today confirmed that it has received an unsolicited and non-binding acquisition proposal from SilverCape Investments Limited, a Singapore-based investment firm, to acquire all of the outstanding shares of the Company for $4 per share in cash, subject to variou...

 PRESS RELEASE

PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets ...

PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them DELRAY BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today unveiled its new Holiday Collection, a curated selection of health, wellness, and lifestyle products designed for pet parents who want to give purposeful, practical gifts this season. Unlike traditional pet gifts such as toys or beds, PetMeds’ giftable assortment focuses on products that improve pets’ everyday health, comfort, safety...

 PRESS RELEASE

PetMeds Extends Existing Shareholder Rights Plan

PetMeds Extends Existing Shareholder Rights Plan DELRAY BEACH, Fla., Nov. 26, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today announced that its Board of Directors (the “Board”) has unanimously approved an amendment to the Company’s existing shareholder rights plan (the “Rights Plan”), pursuant to which the expiration date of the Rights was extended for one year from the close of business on December 2, 2025 until the close of business on December 2, 2026. All other terms and conditions of the Rights Plan ...

 PRESS RELEASE

PetMed Express, Inc. Announces Preliminary Second Quarter Results and ...

PetMed Express, Inc. Announces Preliminary Second Quarter Results and Filing of Form 12b-25; Company Receives Expected Notice of Non-Compliance from Nasdaq DELRAY BEACH, Fla., Nov. 13, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today announced preliminary second quarter fiscal year 2026 results and filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission. The Company is unable to file its Form 10-Q for the quarter ended September 30, 2025 within the prescribed time period...

 PRESS RELEASE

PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as ...

PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as Director and Audit Committee Chair Seasoned corporate director brings extensive expertise in audit, accounting, and internal controls Fourth independent director to join the board since 2024 DELRAY BEACH, Fla., Oct. 20, 2025 (GLOBE NEWSWIRE) -- , d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today announced the appointment, effective immediately, of James LaCamp to the Company’s Board of Directors (the “Board”), and effective October 30, Mr. LaCamp will become Chair of the Audit Commit...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch